All News

Tough week for pharmacy

One bunch of pharmacists won't forget National Pharmacists Week any time soon.

As pharmacists switch from reimbursement based on a fee-for-service model to value-based care, these best practices can help maximize efficiency despite budget constraints and lean staffs.

New Products

New Rx, generics, OTC, and devices

Remember President Eisenhower’s coinage “the military-industrial complex”? Here’s a contemporary analogue, spotlighted in a passionate argument by Drug Topics reader Robert L. Mabee, RPh, JD, MBA.

Hospital pharmacy directors throughout Texas are being repeatedly targeted by grey market drug vendors, according to a new study led by a faculty member at the University of Texas.

The U.S. Pharmacopeial Convention recently joined a number of other global health organizations in the Fight the Fakes campaign to combat the growing problem of counterfeit and substandard medications.

In cancer patients with concurrent type 2 diabetes, metformin alone or in combination with other regimens was associated with 34% reduction in overall death risk and 38% reduction in cancer-specific death risk, according to a study in the December issue of The Oncologist.

Walgreens recently opened what is believed to be the nation’s first zero energy retail store. The Evanston, Ill., store uses approximately 850 solar panels and 2 wind turbines, and is anticipated to produce more energy than it consumes.

FDA has approved sofosbuvir (Sovaldi, Gilead) to treat chronic hepatitis C virus (HCV) infection. According to FDA, Sovaldi is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of interferon.

Do you have the qualities to become an exceptional pharmacy leader? Captain Mark E. Brouker, PharmD, MBA, BCPS, who recently retired from the U.S. Navy's Medical Service Corps after 30 years of service, outlined 3 top leadership qualities during his keynote speech at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Orlando.

A specific type of diabetes drug can decrease the risk of cancer in female patients with type 2 diabetes up to 32%, according to a study published in Diabetes, Obesity and Metabolism. People with type 2 diabetes have a higher rate of cancer development and recurrence compared to the general population.